FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Zinc Acetate Capsules
Status: Currently in Shortage
»Date first posted: 12/15/2020
»Therapeutic Categories: Other; Pediatric

Expand all

Teva Pharmaceuticals (Reverified 02/22/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg, bottle of 250 (NDC 57844-215-52) Unavailable Anticipated recovery by May 2021. http://www.galzin.com/galzin.pdf Other
50 mg, bottle of 250 (NDC 57844-208-52) Limited short-dated stock available until early March 2021 Anticipated recovery by May 2021. http://www.galzin.com/galzin.pdf Other
25 mg zinc acetate dihydrate capsules, bottle of 250 (NDC 57844-376-25) Available Teva is coordinating with the FDA to make available in the U.S, the non-FDA approved pharmaceutically equivalent alternative drug, WILZIN® (zinc acetate dihydrate) 25 mg capsules. To place an order, please contact Teva at 1-888-838-2872.

Dear Healthcare Professional Letter

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English